Bonus Presentations

Please note all sessions listed in Eastern time. Agenda subject to Change.
October
25
7:45 am
8:45 am

This is a Non-CME/CE Presentation

Treating MDD: A Rapid-Acting Oral Antidepressant with Multimodal Activity

Speaker: John J. Miller, MD

Sponsored by Axsome Therapeutics

October
25
1:05 pm
2:05 pm

This is a Non-CME/CE Presentation

Tardive Dyskinesia Is Personal: Go Beyond the Data with a Real Patient Story

Speakers: Jonathan M. Meyer, MD & Deanne C., Patient Ambassador

Sponsored by Neurocrine Biosciences

October
25
6:15 pm
7:00 pm

This is a Non-CME/CE Presentation

Long-Term Strategies in Treatment-Resistant Depression

Speakers: Abid Nazeer, MD & Helen Farrell, MD

Sponsored by Johnson & Johnson Innovative Medicine

October
26
7:10 am
7:55 am

This is a Non-CME/CE Presentation

Come Learn About Innovations in Schizophrenia

Speaker: Henry A. Nasrallah, MD

Sponsored by Bristol Myers Squibb

October
26
12:45 pm
1:45 pm

This is a Non-CME/CE Presentation

An Established Treatment Option for Managing Bipolar I Disorder or Schizophrenia

Speaker: Paul E. Keck, Jr., MD

Sponsored by Alkermes, Inc.

October
26
3:20 pm
4:05 pm

This is a Non-CME/CE Presentation

Exploring Diagnostic Specifiers in Bipolar Disorder and a Treatment Option for BOTH Bipolar I and Bipolar II Depression in Adults

Speaker: Gregory W. Mattingly, MD

Sponsored by Intra-Cellular Therapies

Disclaimer: Bonus Presentations are independently organized and not an official part of the Psychopharmacology Update 2024 program. All presentations are Non-CME unless otherwise noted.